In conventional studies of heterogeneous photocatalytic oxidation, it is crucial to evaluate by means of control experiments the relevance of the “non‐catalyzed” autoxidation reaction under irradiation. If the autoxidation is found to be negligible, it is usually considered that it can be safely disregarded. However, in the case of aromatic aldehydes’ synthesis such as benzaldehyde, irradiating with UV light may lead to a more complex mechanism than previously thought. Herein, we prove that neglecting the autoxidative reaction can lead to a misinterpretation of the mechanism as well as an overestimation of the catalyst's efficiency, even if the control experiment exhibits zero yield. As an example, we studied the synthesis of benzaldehyde from benzyl alcohol by UV‐A irradiation with and without TiO2 and CdS nanoparticles; without catalyst, after a long induction time, the aldehyde enhances its own production through an autocatalytic reaction activated by the same light wavelengths utilized for the nanocatalysts. The long induction time leads to considering the autocatalysis to be deceptively negligible. However, the nanoparticles act as a fast initiator of the benzaldehyde autocatalysis, in such a way that the oxidation rate reached a similar performance with nanoparticles and after removing them. This suggests that the commonly ignored autocatalysis of benzaldehyde indeed is a relevant parallel pathway to the heterogeneous catalysis mechanism.
Allylic and acrylic substrates may be efficiently transformed by a sequential bichromatic photochemical process into derivatives of levulinates or butenolides with high selectivity when phenanthrene is used as a regulator.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.